Aortic Valve Stenosis
What's New
Last Posted: Apr 18, 2024
- Prevalence of elevated lipoprotein(a) in cardiac rehabilitation patients - results from a large-scale multicentre registry in Germany.
Christoph Altmann et al. Clin Res Cardiol 2024 - Coronary artery disease evaluation during transcatheter aortic valve replacement work-up using photon-counting CT and artificial intelligence.
Jan M Brendel et al. Diagn Interv Imaging 2024 - Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
Marina Cuchel et al. J Am Heart Assoc 2023 e029175 - Efficient screening for severe aortic valve stenosis using understandable artificial intelligence: a prospective diagnostic accuracy study.
Hisaki Makimoto et al. European heart journal. Digital health 2023 3(2) 141-152 - Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
Kronenberg Florian et al. European heart journal 2022 - Mendelian Randomization: Principles and its usage in Lp(a) research.
Lamina Claudia et al. Atherosclerosis 2022 5 36-41 - Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review.
Duarte Lau Freddy et al. JAMA cardiology 2022 5 - Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
Björnsson Eythór et al. Arteriosclerosis, thrombosis, and vascular biology 2021 ATVBAHA120315904 - Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
Cohen-Shelly Michal et al. European heart journal 2021 - Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
Pérez de Isla Leopoldo et al. European heart journal 2021 Jan
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source: